Daewoong Pharmaceutical’s Nabota Hits 1 Trillion Won in Cumulative Sales 12 Years Post-Launch
Daewoong Pharmaceutical announced on the 13th that its flagship botulinum toxin product, Nabota, surpassed 1 trillion won in cumulative sales as of...
Search results for "Pharmaceutical Research"
Maximizing Weight Loss vs. Protecting the Heart: The Paradox of Modern Anti-Obesity Drugs
As global demand for anti-obesity medications surges, a fierce pharmaceutical race is underway to develop next-generation successors to blockbusters...
Daewoong’s Enblo Demonstrates Strong Potential to Reverse Fatty Liver in Diabetes Patients
Daewoong Pharmaceutical announced that its newly developed type 2 diabetes medication, Enblo (active ingredient:...
AI Cancer Gene Analysis and 810 Billion-Won Tech Export Lead South Korea's Top 30 Health Care R&D Achievements
The Ministry of Health and Welfare and the Korea Health Industry Development Institute announced on the 8th that they...
Unlocking the ‘Treasure’ in Belly Fat: Why Liposuction Specialist Kim Jung-eun is Championing Adipose Stem Cells
For more than 20 years, she incinerated belly fat. She saw it as treasure. Why liposuction specialist Dr.
Daewoong Pharmaceutical Secures 145.2 Billion Won MENA Export Deal for Diabetes Drug Enblo
Daewoong Pharmaceutical’s proprietary type 2 diabetes treatment, Enblo (active ingredient: enavogliflozin), is set to...
Fueling the Future of Biohealth: InterBiz Forum Opens in Jeju With a Record 1,500 Tech Deals
The 24th InterBiz Bio Partnering & Investment Forum 2026, a premier biohealth technology deal-making event, opened...
Diabetes Drug Repurposed: Evogliptin Shows Promise in Preventing Disfiguring Burn Scars
Burn survivors frequently face a distressing secondary complication known as hypertrophic scarring, where the skin...
SCL Healthcare Secures U.S. Patent for Genetic Test Predicting Metabolic Syndrome Risk
SCL Healthcare has successfully secured a U.S. patent for a novel genetic testing technology designed to predict an...
MSD Bets $510M on High-Quality Data to Fuel Post-Keytruda AI Drug Discovery
MSD, which has long dominated the global cancer market with its blockbuster immuno-oncology therapy Keytruda, is...